The Clinical Study of Apatinib Plus S1 for Patients With Advanced Non-squamous Head and Neck Cancer
Status:
Unknown status
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This is a Single-center, Open-label, Single-arm, Phase Ⅱ exploratory clinical trial
evaluating the efficacy and safety of Apatinib plus S1 for patients with advanced
(unresectable, locally advanced, recurrent or metastatic) non-squamous head and neck cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences